A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in dep vein thrombosis. A phase II evaluation

H. R. Büller; A. T. Cohen; A. W. A. Lensing; M. Monreal; M. H. Prins; S. Schulman; M. R. Lassen; R. G. M. van Amsterdam

A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in dep vein thrombosis. A phase II evaluation

H. R. Büller, A. T. Cohen, A. W. A. Lensing, M. Monreal, M. H. Prins, S. Schulman, M. R. Lassen, R. G. M. van Amsterdam

Vascular Medicine (AMC)

Research output: Contribution to journal › Article › Academic › peer-review

143 Citations (Scopus)

Original language	English
Pages (from-to)	47-53
Journal	Journal of thrombosis and haemostasis
Volume	2
Issue number	1
Publication status	Published - 2004

Cite this

@article{b1184751ac16432691c88b343f381aa0,

title = "A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in dep vein thrombosis. A phase II evaluation",

author = "B{\"u}ller, {H. R.} and Cohen, {A. T.} and Lensing, {A. W. A.} and M. Monreal and Prins, {M. H.} and S. Schulman and Lassen, {M. R.} and {van Amsterdam}, {R. G. M.}",

year = "2004",

language = "English",

volume = "2",

pages = "47--53",

journal = "Journal of thrombosis and haemostasis",

issn = "1538-7933",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in dep vein thrombosis. A phase II evaluation

AU - Büller, H. R.

AU - Cohen, A. T.

AU - Lensing, A. W. A.

AU - Monreal, M.

AU - Prins, M. H.

AU - Schulman, S.

AU - Lassen, M. R.

AU - van Amsterdam, R. G. M.

PY - 2004

Y1 - 2004

M3 - Article

SN - 1538-7933

VL - 2

SP - 47

EP - 53

JO - Journal of thrombosis and haemostasis

JF - Journal of thrombosis and haemostasis

IS - 1

ER -